Cardiovascular Disease in Singleton Offspring Born of Pregnancies Complicated by Placental Abruption: A

Cande V Ananth1,2,3,4,5, Emily B Rosenfeld1,6, Rachel Lee1

  • 1Division of Epidemiology and Biostatistics, Department of Obstetrics, Gynecology, and Reproductive Sciences Rutgers Robert Wood Johnson Medical School New Brunswick NJ.

Insights

Children born after placental abruption face higher risks of death and cardiovascular disease (CVD). These risks, linked to placental dysfunction, emerge early and continue throughout life.

Area of Science:

  • Perinatal Medicine
  • Cardiovascular Epidemiology
  • Pediatric Health

Background:

  • Placental abruption is a known risk factor for maternal cardiovascular disease (CVD).
  • Offspring risks for mortality and CVD following placental abruption are not well-established.
  • This study investigates the association between placental abruption and offspring mortality and CVD events.

Purpose of the Study:

  • To examine the association between placental abruption during pregnancy and the risk of all-cause mortality in offspring.
  • To assess the risk of fatal and nonfatal cardiovascular disease (CVD) events in offspring exposed to placental abruption.
  • To determine if these risks persist throughout the offspring's life course.

Main Methods:

  • Retrospective cohort study utilizing the PACER cohort (New Jersey, 1993-2020).
  • Cox proportional hazards models were used to estimate risks associated with abruption.
  • Sibling-pair analyses were conducted to control for familial confounding.

Main Results:

  • Offspring born after placental abruption had significantly higher rates of CVD mortality (aHR, 4.64) and nonfatal CVD events (aHR, 2.86).
  • Elevated risks were observed even in the first year of life and persisted over a median follow-up of 14.5 years.
  • Sibling-pair analyses confirmed the associations, indicating a link beyond shared familial factors.

Conclusions:

  • Pregnancies complicated by placental abruption increase the offspring's long-term burden of mortality and cardiovascular disease.
  • The heightened CVD risk associated with abruption is apparent from infancy and continues across the lifespan.
  • Placental dysfunction in abruption may contribute to the offspring's future cardiovascular risk profile.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.5K
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
4.4K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.3K
Development of Blood Vessels01:07

Development of Blood Vessels

The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
1.8K
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
526